The cost of decoding our genetic makeup has plummeted. Just because it’s affordable doesn’t necessarily mean it’s worth doing ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

The Environment Agency – Abu Dhabi (EAD) has partnered with M42 for a genome sequencing project at the Plant Genetic Resources Centre. The project will decode the genetic makeup and adaptive ...

“The research that’s needed most is the risk stratification research—who do we screen,” says Dr. Gabre. By getting to the ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by ...

A research team led by Prof. Sun Chaomin from the Institute of Oceanology of the Chinese Academy of Sciences (IOCAS) has ...

When scientists sequenced the first Neanderthal genomes, they did not just resurrect a lost branch of the human family tree, ...

Experienced senior executive brings proven track record in financial strategy, operational excellence, and commercial executionEMERYVILLE, Calif.--(BUSINESS WIRE)--#50kb--Ansa Biotechnologies Inc., ...